Citigroup Maintains Neutral on Medtronic, Raises Price Target to $92
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch maintains a Neutral rating on Medtronic (NYSE:MDT) but raises the price target from $85 to $92.
October 01, 2024 | 4:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup analyst Joanne Wuensch maintains a Neutral rating on Medtronic but raises the price target from $85 to $92, indicating a positive outlook.
The increase in the price target from $85 to $92 suggests a positive outlook for Medtronic, which could lead to a short-term increase in stock price. However, the Neutral rating indicates that the analyst does not expect significant outperformance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100